Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,208,502
-$333,792 QoQ
Shares Held
50,187
-8.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,210
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERIDIAN INVESTMENT COUNSEL INC. holds $23,634,584 across 8 Drug Manufacturers - General names. PFE ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,506 | $6,418,329 | |
| 2 | JNJ |
Johnson & Johnson
|
22,704 | $5,766,134 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
31,450 | $3,973,393 | |
| 4 | NVO |
Novo Nordisk A S
|
63,091 | $3,024,582 | |
| 5 | AMGN |
Amgen Inc
|
6,995 | $2,533,029 | |
| 6 | PFE |
Pfizer Inc
This page
|
50,187 | $1,208,502 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,923 | $504,105 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,584 | $206,510 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,208,502 | 50,187 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,542,294 | 54,925 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,581,224 | 63,503 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,734,551 | 68,075 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,682,862 | 69,425 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,770,607 | 69,874 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,728,615 | 65,157 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,823,798 | 63,020 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,816,209 | 64,911 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,790,180 | 64,511 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,882,232 | 65,378 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,170,744 | 65,443 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,459,137 | 67,043 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,776,154 | 68,043 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,491,134 | 68,133 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $3,040,007 | 69,470 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,818,214 | 72,825 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,837,451 | 74,125 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,377,081 | 74,125 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,234,481 | 75,203 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $2,950,823 | 75,353 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $2,675,694 | 73,853 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $2,717,755 | 73,832 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,659,316 | 72,461 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,327,882 | 71,189 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,313,095 | 70,867 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||